Table 5.
Biochemical and clinical outcomes in the pre and post- implantation cohorts
| Variables # | PRE group (n = 69) |
POST group (n = 70) | P-value* |
|---|---|---|---|
| BUN | 54.8 ± 26.2 | 53.3 ± 24 | 0.713 |
| Cr | 0.88 ± 0.35 | 0.80 ± 0.33 | 0.188 |
| Total bilirubin | 8.0 ± 1.9 | 8.2 ± 2.0 | 0.607 |
| Hypoglycemia | 4 (5.8%) | 7 (10%) | 0.359 |
| Hyperglycemia | 23 (33.3%) | 16 (22.9%) | 0.169 |
| Length of NICU stay (day) | 43.1 ± 22.9 | 40.2 ± 18.2 | 0.106 |
| Length of NICU stay (day) | 0.311 | ||
|
- 40 - 40–60 - > 60 |
31 (50%) 24 (38.7%) 7 (11.3%) |
29 (46.8%) 30 (48.4%) 3 (4.8%) |
|
| Length of hospital stay (day) | 53.0 ± 25.6 | 52.0 ± 20.4 | 0.082 |
| Length of hospital stay (day) | 0.040 | ||
|
- 60 - 60–90 - > 90 |
39 (62.9%) 15 (24.2%) 8 (12.9%) |
40 (64.5%) 21 (33.9%) 1 (1.6%) |
|
| Sepsis | |||
|
- Positive blood culture - Positive urine culture |
16 (23.2%) 2 (2.9%) |
7 (10%) 4 (5.7%) |
0.036 0.414 |
| Respiratory support | |||
|
- SIMV - NCPAP - HFNC |
28 (40.6%) 68 (98.6%) 64 (92.8%) |
34 (48.6%) 70 (100%) 69 (98.6%) |
0.343 0.312 0.092 |
| NEC (Stage II) | 4 (5.8%) | 4 (6.1%) | 0.948 |
| IVH | 16 (23.5%) | 13 (18.8%) | 0.502 |
| ROP | 6 (8.8%) | 2 (2.9%) | 0.145 |
| Discharge to home | 59 (85.8%) | 61 (87.1%) | 0.779 |
| Referred | 3 (4.3%) | 1 (1.4%) | 0.303 |
| Expired | 7 (10.1%) | 8 (11.4%) | 0.807 |
Note. SIMV = Synchronized intermittent mandatory ventilation; NCPAP = Nasal continuous positive airway pressure; HFNC = High-flow nasal cannula; Hypoglycemia = Blood glucose < 50 mg/dl; Hyperglycemia = Blood glucose > 150 mg/dl; BUN = Blood urea nutrition; Cr = Creatinine; NEC = Necrotizing enterocolitis; IVH = Intraventricular hemorrhage; ROP = retinopathy of prematurity
# Mean ± SD for numeric variables and number (percent) for categorical variables
*Independent samples t test for numeric variables and Pearson chi-square test for categorical variables